← All indications
Leukoencephalopathies
Any of various diseases affecting the white matter of the central nervous system.
Subtype terms (5)
More specific conditions that are subtypes of Leukoencephalopathies in the MeSH hierarchy.
- Dementia, Vascular
51 drugs (32 approved, 19 experimental)
- Demyelinating Autoimmune Diseases, CNS
10 drugs (8 approved, 2 experimental)
- Hereditary Central Nervous System Demyelinating Diseases
- Leukoencephalopathy, Progressive Multifocal
21 drugs (16 approved, 5 experimental)
- Posterior Leukoencephalopathy Syndrome
Drugs by status
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (11)
- SmithKline Beecham
- Bristol-Myers Squibb
- Roche
- Gilead Sciences
- Upjohn
- French National Agency for Research on AIDS and Viral Hepatitis
- National Institute of Allergy and Infectious Diseases (NIAID)
- Zhejiang University
- University of Minnesota
- Washington University in St. Louis
- Assistance Publique - Hôpitaux de Paris
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (1)